mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
0.0006 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.003 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.004 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |